BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6ad7df10cc1eb@umanitoba.ca
SUMMARY:New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) - Internal Deadline
DESCRIPTION:New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)\n\nThis competitive grant program seeks to support independent medical education addressing the new mechanisms in mCRPC including EZH2 inhibition and its possible role in prostate cancer and the continued unmet need for novel therapies in mCRPC.\n\nIndividual projects requesting up to $250,000 USD will be considered.  Maximum project length is 18-24 months. \n\n\nInternal Application Deadline: Sep 29, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4426\n\nProgram URL: https://cdn.pfizer.com/pfizercom/2026-09/2026%20IME_RFP_New%20Mechanisms%20in%20Prostate%20Cancer.pdf?VersionId=9HOOg4i7iXh7_tPCNIyrzv2pwFqiyyJm\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:<html><body>New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)<br /><br />This competitive grant program seeks to support independent medical education addressing the new mechanisms in mCRPC including EZH2 inhibition and its possible role in prostate cancer and the continued unmet need for novel therapies in mCRPC.<br /><br />Individual projects requesting up to $250\,000 USD will be considered.  Maximum project length is 18-24 months. <br /><br /><br />Internal Application Deadline: Sep 29\, 2026 <br /><br />UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4426<br /><br />Program URL: https://cdn.pfizer.com/pfizercom/2026-09/2026%20IME_RFP_New%20Mechanisms%20in%20Prostate%20Cancer.pdf?VersionId=9HOOg4i7iXh7_tPCNIyrzv2pwFqiyyJm</body></html>
DTSTART:20260929T083000
DTEND:20260929T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
END:VALARM
END:VEVENT
END:VCALENDAR